Treatment response to cyclophosphamide, rituximab, and bortezomib in chronic immune-mediated sensorimotor neuropathies: a retrospective cohort study.

Jeremias Motte Anna Lena FisseNuray KöseThomas GrüterHannah MorkDiamantis AthanasopoulosMiriam FelsSusanne OttoInes SiglientiChristiane Schneider-GoldKerstin HellwigMin-Suk YoonRalf GoldKalliopi Pitarokoili

Published in: Therapeutic advances in neurological disorders (2021)

Treatment with CYP, RTX, or BTZ was effective in this cohort of CIN refractory to first-line treatment. Our data increase evidence for an early use of these therapies. High efficacy of RTX in Lewis-Sumner syndrome in contrast to typical CIDP suggests a distinct pathophysiology.

Keyphrases

magnetic resonance
low dose
diffuse large b cell lymphoma
electronic health record
multiple myeloma
high dose
functional connectivity
magnetic resonance imaging
newly diagnosed
machine learning
artificial intelligence
combination therapy
deep learning
drug induced